We are live on ! Find out more
MRNS

Marinus Pharmaceuticals, Inc

Delisted

MRNS was delisted on the 10th of February, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$20.9M
Jennison Associates
2
Jennison Associates
New York
$17.6M -$1.22M -70,040 -6%
BlackRock
3
BlackRock
New York
$14.2M +$998K +57,453 +7%
GPCM
4
Granite Point Capital Management
Massachusetts
$13.9M +$1.28M +73,853 +10%
Vanguard Group
5
Vanguard Group
Pennsylvania
$10.7M +$501K +28,824 +5%
Franklin Resources
6
Franklin Resources
California
$10.1M
Goldman Sachs
7
Goldman Sachs
New York
$7.61M +$49.5K +2,853 +0.6%
6CM
8
683 Capital Management
New York
$5.81M
VMI
9
VHCP Management III
New York
$5.22M
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$4.16M +$4.35M +250,479 New
State Street
11
State Street
Massachusetts
$3.69M +$763K +43,921 +25%
VMI
12
VHCP Management II
New York
$3.09M
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.75M +$250K +14,370 +9%
Northern Trust
14
Northern Trust
Illinois
$2.28M +$44.3K +2,551 +2%
O
15
OrbiMed
New York
$1.65M
ECM
16
Endurant Capital Management
California
$1.5M -$326K -18,778 -17%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$1.48M +$1.03M +59,532 +202%
Citadel Advisors
18
Citadel Advisors
Florida
$1.35M -$219K -12,597 -13%
FI
19
Fosun International
China
$1.12M -$460K -26,500 -27%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$898K +$757K +43,577 +415%
Morgan Stanley
21
Morgan Stanley
New York
$780K +$770K +44,332 +1,679%
Nuveen
22
Nuveen
North Carolina
$776K +$811K +46,699 New
BCM
23
Bridgeway Capital Management
Texas
$770K +$217K +12,500 +37%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$569K -$33K -1,902 -5%
Charles Schwab
25
Charles Schwab
California
$527K +$136K +7,815 +33%